ClinicalTrials.gov
ClinicalTrials.gov Menu

Reevaluation Of Systemic Early Neuromuscular Blockade (ROSE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02509078
Recruitment Status : Active, not recruiting
First Posted : July 27, 2015
Last Update Posted : April 18, 2018
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
David Alan Schoenfeld, Massachusetts General Hospital